Janney Montgomery Scott LLC Inmune Bio, Inc. Transaction History

Janney Montgomery Scott LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$7.15 - $11.84 $852,444 - $1.41 Million	-119,223 Reduced 84.61%	21,688 $191,000
Q1 2024 May 01, 2024	SELL	$10.53 - $14.01 $238,483 - $317,298	-22,648 Reduced 13.85%	140,911 $1.66 Million
Q4 2023 Feb 07, 2024	SELL	$6.6 - $11.52 $615,964 - $1.08 Million	-93,328 Reduced 36.33%	163,559 $1.84 Million
Q3 2023 Nov 08, 2023	BUY	$6.61 - $10.9 $214,706 - $354,053	32,482 Added 14.47%	256,887 $1.74 Million
Q2 2023 Jul 26, 2023	SELL	$6.5 - $10.09 $97,779 - $151,783	-15,043 Reduced 6.28%	224,405 $2.04 Million
Q1 2023 Apr 28, 2023	BUY	$6.01 - $10.18 $89,362 - $151,366	14,869 Added 6.62%	239,448 $1.55 Million
Q4 2022 Feb 01, 2023	BUY	$6.13 - $7.96 $178,340 - $231,580	29,093 Added 14.88%	224,579 $1.42 Million
Q3 2022 Oct 25, 2022	SELL	$6.04 - $10.44 $95,625 - $165,286	-15,832 Reduced 7.49%	195,486 $1.21 Million
Q2 2022 Aug 03, 2022	SELL	$5.48 - $8.97 $270,668 - $443,046	-49,392 Reduced 18.95%	211,318 $1.73 Million
Q1 2022 May 04, 2022	BUY	$6.42 - $11.39 $942,430 - $1.67 Million	146,796 Added 128.87%	260,710 $2.2 Million
Q4 2021 Jan 27, 2022	BUY	$9.97 - $20.38 $145,472 - $297,364	14,591 Added 14.69%	113,914 $1.16 Million
Q3 2021 Oct 29, 2021	BUY	$14.13 - $27.85 $593,219 - $1.17 Million	41,983 Added 73.22%	99,323 $1.93 Million
Q2 2021 Jul 26, 2021	BUY	$9.29 - $19.33 $532,688 - $1.11 Million	57,340 New	57,340 $1.01 Million

5.92M

243K

46.4K

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $82M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.